Reaction to drugs from the main opposition and pharmacists in Greece
Tsipras, who met with Konstandinos Lurandos, president of the Atiki Region Pharmacists Association, and other representatives, said action should be taken as soon as possible, drawing attention to the shortage of medicines in the country.
Tsipras stated that he is concerned about the increase in cases of Covid-19 and diseases caused by viruses throughout the country, and stated that citizens’ access to medicines is a “vital issue”.
Tsipras, who affirmed that the supply of medicines must be secured with inspections in the pharmaceutical market and pharmaceutical warehouses and a ban on exporting medicines, said for the government: “Once again, it allows a problem to turn into a crisis.” he made the comment of him.
Tsipras stated that the problems related to the supply of medicines have been going on for about a year and argued that the government condoned the export of some medicines that are cheap in Greece to the European market with a higher share of the profits.
PHARMACISTS WHO COMPLAINED FOR MORE THAN A YEAR OF IGNORING WARNINGS
According to news from the Greek state agency AMNA, Lurando drew attention to the dimensions of the anguish, saying: “I have been in this profession for 44 years, I have never experienced anything like this before.” he said.
Stating that pharmacists have been warning about drug shortages for more than a year, Lurandos claimed that the Ministry of Health did not take these warnings into account.
Lurandos argued that exports of some medicines have doubled in the last year.
THE GOVERNMENT HAS DECIDED TO TAKE NEW MEASURES
In a meeting where Greek Health Minister Thanos Plevris and pharmaceutical representatives discussed drug supply problems on Monday, January 2, frequent inspections of pharmaceutical warehouses to prevent the export of these drugs, the closure of pharmaceutical warehouses that do not comply with the export ban or that stock medicines for a while, mainly antipyretics and antipyretic drugs. It was decided to take a series of measures, such as the adequacy control of medicines in pharmaceutical companies, especially medicines used in the treatment of children.
Plevris then sent a letter to the European Union (EU) health commissioner about the drug shortages the country is facing, arguing that countries should act together to solve the drug shortage problem facing all countries in the EU. EU. (AA)